Contribution of Bordetella bronchiseptica filamentous hemagglutinin and pertactin to respiratory disease in swine

Infection and Immunity

Volumn 77, Issue 5, 2009, Pages 2136-2146

  Nicholson, Tracy L ^a   Brockmeier, Susan L ^a   Loving, Crystal L ^a  

^a NATIONAL ANIMAL DISEASE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; BORDETELLA ANTIBODY; HEMAGGLUTININ; MUTANT PROTEIN; PERTACTIN; UNCLASSIFIED DRUG; ADHESIN; BORDETELLA VIRULENCE FACTOR; FHA PROTEIN, BORDETELLA BRONCHISEPTICA; OUTER MEMBRANE PROTEIN; VIRULENCE FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; BORDETELLA BRONCHISEPTICA; BORDETELLA BRONCHISEPTICA INFECTION; CELL ADHESION; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; GENE DELETION; IN VITRO STUDY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SCORING SYSTEM; STRUCTURAL GENE; SWINE DISEASE; TURBINATE; WILD TYPE; ANIMAL; ANIMAL DISEASE; BACTERIAL COUNT; BLOOD; BORDETELLOSIS; GENETICS; HOSPITALIZATION; MICROBIOLOGY; PATHOGENICITY; PATHOLOGY; PHYSIOLOGY; RESPIRATORY SYSTEM; SWINE;

ADHESINS, BACTERIAL; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; BORDETELLA BRONCHISEPTICA; BORDETELLA INFECTIONS; COLONY COUNT, MICROBIAL; GENE DELETION; RESPIRATORY SYSTEM; SEVERITY OF ILLNESS INDEX; SWINE; SWINE DISEASES; VIRULENCE FACTORS; VIRULENCE FACTORS, BORDETELLA;

EID: 65449172445     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01379-08     Document Type: Article

References (74)

1. Akerley, B. J., P. A. Cotter, and J. F. Miller. 1995. Ectopic expression of the flagellar regulon alters development of the Bordetella-host interaction. Cell 80:611-620.
2. Arico, B., S. Nuti, V. Scarlato, and R. Rappuoli. 1993. Adhesion of Bordetella pertussis to eukaryotic cells requires a time-dependent export and maturation of filamentous hemagglutinin. Proc. Natl. Acad. Sci. USA 90:9204-9208.
3. Baysinger, A. 1999. PRDC: is it new or deja vu? Pork 19:64.
4. Boessen, C. R., J. B. Kliebenstein, R. P. Cowart, K. C. Moore, and C. R. Burbee. 1988. Effective use of slaughter checks to determine economic losses from morbidity in swine. Acta Vet. Scand. Suppl. 84:366-368.
5. Brennan, M. J., Z. M. Li, J. L. Cowell, M. E. Bisher, A. C. Steven, P. Novotny, and C. R. Manclark. 1988. Identification of a 69-kilodalton nonfimbrial protein as an agglutinogen of Bordetella pertussis. Infect. Immun. 56:3189-3195.
6. Brockmeier, S. L. 2004. Prior infection with Bordetella bronchiseptica increases nasal colonization by Haemophilus parasuis in swine. Vet. Microbiol. 99:75-78.
7. Brockmeier, S. L., P. G. Halbur, and E. L. Thacker. 2002. Porcine respiratory disease complex, p. 231-258. In K. A. Brogden and J. Guthmiller (ed.), Polymicrobial diseases. ASM Press, Washington, DC.
8. Brockmeier, S. L., and K. M. Lager. 2002. Experimental airborne transmission of porcine reproductive and respiratory syndrome virus and Bordetella bronchiseptica. Vet. Microbiol. 89:267-275.
9. Brockmeier, S. L., C. L. Loving, T. L. Nicholson, and M. V. Palmer. 2008. Coinfection of pigs with porcine respiratory coronavirus and Bordetella bronchiseptica. Vet. Microbiol. 128:36-47.
10. Brockmeier, S. L., M. V. Palmer, and S. R. Bolin. 2000. Effects of intranasal inoculation of porcine reproductive and respiratory syndrome virus, Bordetella bronchiseptica, or a combination of both organisms in pigs. Am. J. Vet. Res. 61:892-899.
11. Brockmeier, S. L., M. V. Palmer, S. R. Bolin, and R. B. Rimler. 2001. Effects of intranasal inoculation with Bordetella bronchiseptica, porcine reproductive and respiratory syndrome virus, or a combination of both organisms on subsequent infection with Pasteurella multocida in pigs. Am. J. Vet. Res. 62:521-525. (Pubitemid 33605771)
12. Brockmeier, S. L., and K. B. Register. 2007. Expression of the dermonecrotic toxin by Bordetella bronchiseptica is not necessary for predisposing to infection with toxigenic Pasteurella multocida. Vet. Microbiol. 125:284-289. (Pubitemid 47588661)
13. Brockmeier, S. L., K. B. Register, T. Magyar, A. J. Lax, G. D. Pullinger, and R. A. Kunkle. 2002. Role of the dermonecrotic toxin of Bordetella bronchiseptica in the pathogenesis of respiratory disease in swine. Infect. Immun. 70:481-490.
14. Cotter, P. A., and A. M. Jones. 2003. Phosphorelay control of virulence gene expression in Bordetella. Trends Microbiol. 11:367-373. (Pubitemid 37289277)
15. Cotter, P. A., and J. F. Miller. 1994. BvgAS-mediated signal transduction: analysis of phase-locked regulatory mutants of Bordetella bronchiseptica in a rabbit model. Infect. Immun. 62:3381-3390.
16. Cotter, P. A., M. H. Yuk, S. Mattoo, B. J. Akerley, J. Boschwitz, D. A. Relman, and J. F. Miller. 1998. Filamentous hemagglutinin of Bordetella bronchiseptica is required for efficient establishment of tracheal colonization. Infect. Immun. 66:5921-5929.
17. Donnenberg, M. S., and J. B. Kaper. 1991. Construction of an eae deletion mutant of enteropathogenic Escherichia coli by using a positive-selection suicide vector. Infect. Immun. 59:4310-4317.
18. Emsley, P., I. G. Charles, N. F. Fairweather, and N. W. Isaacs. 1996. Structure of Bordetella pertussis virulence factor P.69 pertactin. Nature 381:90-92.
19. Everest, P., J. Li, G. Douce, I. Charles, J. De Azavedo, S. Chatfield, G. Dougan, and M. Roberts. 1996. Role of the Bordetella pertussis P.69/pertactin protein and the P.69/pertactin RGD motif in the adherence to and invasion of mammalian cells. Microbiology 142(Pt. 11):3261-3268.
20. Giardina, P. C., L. A. Foster, J. M. Musser, B. J. Akerley, J. F. Miller, and D. W. Dyer. 1995. bvg repression of alcaligin synthesis in Bordetella bronchiseptica is associated with phylogenetic lineage. J. Bacteriol. 177:6058-6063.
21. Guedin, S., E. Willery, C. Locht, and F. Jacob-Dubuisson. 1998. Evidence that a globular conformation is not compatible with FhaC-mediated secretion of the Bordetella pertussis filamentous haemagglutinin. Mol. Microbiol. 29:763-774.
22. Guerrero, R. J. 1990. Respiratory disease: an important global problem in the swine industry, p. 98. Proc. 11th Int. Pig Vet. Soc., Lausanne, Switzerland.
23. Hannah, J. H., F. D. Menozzi, G. Renauld, C. Locht, and M. J. Brennan. 1994. Sulfated glycoconjugate receptors for the Bordetella pertussis adhesin filamentous hemagglutinin (FHA) and mapping of the heparin-binding domain on FHA. Infect. Immun. 62:5010-5019.
24. Harvill, E. T., P. A. Cotter, M. H. Yuk, and J. F. Miller. 1999. Probing the function of Bordetella bronchiseptica adenylate cyclase toxin by manipulating host immunity. Infect. Immun. 67:1493-1500.
25. Hazenbos, W. L., B. M. van den Berg, J. W. van't Wout, F. R. Mooi, and R. van Furth. 1994. Virulence factors determine attachment and ingestion of nonopsonized and opsonized Bordetella pertussis by human monocytes. Infect. Immun. 62:4818-4824.
26. Inatsuka, C. S., S. M. Julio, and P. A. Cotter. 2005. Bordetella filamentous hemagglutinin plays a critical role in immunomodulation, suggesting a mechanism for host specificity. Proc. Natl. Acad. Sci. USA 102:18578-18583.
27. Ishibashi, Y., S. Claus, and D. A. Relman. 1994. Bordetella pertussis filamentous hemagglutinin interacts with a leukocyte signal transduction complex and stimulates bacterial adherence to monocyte CR3 (CD11b/CD18). J. Exp. Med. 180:1225-1233.
28. Ishibashi, Y., and A. Nishikawa. 2002. Bordetella pertussis infection of human respiratory epithelial cells upregulates intercellular adhesion molecule-1 expression: role of filamentous hemagglutinin and pertussis toxin. Microb. Pathog. 33:115-125.
29. Ishibashi, Y., and A. Nishikawa. 2003. Role of nuclear factor-κB in the regulation of intercellular adhesion molecule 1 after infection of human bronchial epithelial cells by Bordetella pertussis. Microb. Pathog. 35:169-177. (Pubitemid 37011150)
30. Jacob-Dubuisson, F., C. Buisine, N. Mielcarek, E. Clement, F. D. Menozzi, and C. Locht. 1996. Amino-terminal maturation of the Bordetella pertussis filamentous haemagglutinin. Mol. Microbiol. 19:65-78.
31. Jacob-Dubuisson, F., C. El-Hamel, N. Saint, S. Guedin, E. Willery, G. Molle, and C. Locht. 1999. Channel formation by FhaC, the outer membrane protein involved in the secretion of the Bordetella pertussis filamentous hemagglutinin. J. Biol. Chem. 274:37731-37735.
32. Khelef, N., C. M. Bachelet, B. B. Vargaftig, and N. Guiso. 1994. Characterization of murine lung inflammation after infection with parental Bordetella pertussis and mutants deficient in adhesins or toxins. Infect. Immun. 62:2893-2900.
33. Kobisch, M., and P. Novotny. 1990. Identification of a 68-kilodalton outer membrane protein as the major protective antigen of Bordetella bronchiseptica by using specific-pathogen-free piglets. Infect. Immun. 58:352-357.
34. Kuper, C. F., P. J. Koornstra, D. M. Hameleers, J. Biewenga, B. J. Spit, A. M. Duijvestijn, P. J. van Breda Vriesman, and T. Sminia. 1992. The role of nasopharyngeal lymphoid tissue. Immunol. Today 13:219-224.
35. Leininger, E., P. G. Probst, M. J. Brennan, and J. G. Kenimer. 1993. Inhibition of Bordetella pertussis filamentous hemagglutinin-mediated cell adherence with monoclonal antibodies. FEMS Microbiol. Lett. 106:31-38.
36. Leininger, E., M. Roberts, J. G. Kenimer, I. G. Charles, N. Fairweather, P. Novotny, and M. J. Brennan. 1991. Pertactin, an Arg-Gly-Asp-containing Bordetella pertussis surface protein that promotes adherence of mammalian cells. Proc. Natl. Acad. Sci. USA 88:345-349.
37. Littell, R. C., G. A. Milliken, W. W. Stroup, R. D. Wolfinger, and O. Schabenberber. 1996. SAS for mixed models, 2nd ed. SAS Institute, Inc., Cary, NC.
38. -ΔΔCT method. Methods 25:402-408.
39. Mann, P., E. Goebel, J. Barbarich, M. Pilione, M. Kennett, and E. Harvill. 2007. Use of a genetically defined double mutant strain of Bordetella bronchiseptica lacking adenylate cyclase and type III secretion as a live vaccine. Infect. Immun. 75:3665-3672.
40. Mattoo, S., J. F. Miller, and P. A. Cotter. 2000. Role of Bordetella bronchiseptica fimbriae in tracheal colonization and development of a humoral immune response. Infect. Immun. 68:2024-2033.
41. Menozzi, F. D., P. E. Boucher, G. Riveau, C. Gantiez, and C. Locht. 1994. Surface-associated filamentous hemagglutinin induces autoagglutination of Bordetella pertussis. Infect. Immun. 62:4261-4269.
42. Menozzi, F. D., R. Mutombo, G. Renauld, C. Gantiez, J. H. Hannah, E. Leininger, M. J. Brennan, and C. Locht. 1994. Heparin-inhibitable lectin activity of the filamentous hemagglutinin adhesin of Bordetella pertussis. Infect. Immun. 62:769-778.
43. Montaraz, J. A., P. Novotny, and J. Ivanyi. 1985. Identification of a 68-kilodalton protective protein antigen from Bordetella bronchiseptica. Infect. Immun. 47:744-751.
44. Musser, J. M., D. A. Bemis, H. Ishikawa, and R. K. Selander. 1987. Clonal diversity and host distribution in Bordetella bronchiseptica. J. Bacteriol. 169:2793-2803.
45. Nicholson, T. L. 2007. Construction and validation of a first-generation Bordetella bronchiseptica long-oligonucleotide microarray by transcriptional profiling the Bvg regulon. BMC Genomics 8:220.
46. Novotny, P., M. Kobisch, K. Cownley, A. P. Chubb, and J. A. Montaraz. 1985. Evaluation of Bordetella bronchiseptica vaccines in specific-pathogen-free piglets with bacterial cell surface antigens in enzyme-linked immunosorbent assay. Infect. Immun. 50:190-198.
47. Parkhill, J., M. Sebaihia, A. Preston, L. D. Murphy, N. Thomson, D. E. Harris, M. T. Holden, C. M. Churcher, S. D. Bentley, K. L. Mungall, A. M. Cerdeno-Tarraga, L. Temple, K. James, B. Harris, M. A. Quail, M. Achtman, R. Atkin, S. Baker, D. Basham, N. Bason, I. Cherevach, T. Chillingworth, M. Collins, A. Cronin, P. Davis, J. Doggett, T. Feltwell, A. Goble, N. Hamlin, H. Hauser, S. Holroyd, K. Jagels, S. Leather, S. Moule, H. Norberczak, S. O'Neil, D. Ormond, C. Price, E. Rabbinowitsch, S. Rutter, M. Sanders, D. Saunders, K. Seeger, S. Sharp, M. Simmonds, J. Skelton, R. Squares, S. Squares, K. Stevens, L. Unwin, S. Whitehead, B. G. Barrell, and D. J. Maskell. 2003. Comparative analysis of the genome sequences of Bordetella pertussis, Bordetella parapertussis, and Bordetella bronchiseptica. Nat. Genet. 35:32-40.
48. Perry, M. E., Y. Mustafa, S. T. Licence, D. Smith, and A. Whyte. 1997. Pig palatine tonsil as a functional model for the human. Clin. Anat. 10:358.
49. Phillips, G. J. 1999. Alteration of open reading frames by use of new gene cassettes. Anal. Biochem. 269:207-210. (Pubitemid 29174285)
50. Pishko, E. J., G. S. Kirimanjeswara, M. R. Pilione, L. Gopinathan, M. J. Kennett, and E. T. Harvill. 2004. Antibody-mediated bacterial clearance from the lower respiratory tract of mice requires complement component C3. Eur. J. Immunol. 34:184-193. (Pubitemid 38111534)
51. Pracy, J. P., A. White, Y. Mustafa, D. Smith, and M. E. Perry. 1998. The comparative anatomy of the pig middle ear cavity: a model for middle ear inflammation in the human? J. Anat. 192(Pt. 3):359-368.
52. Prasad, S. M., Y. Yin, E. Rodzinski, E. I. Tuomanen, and H. R. Masure. 1993. Identification of a carbohydrate recognition domain in filamentous hemagglutinin from Bordetella pertussis. Infect. Immun. 61:2780-2785. (Pubitemid 23182269)
53. Register, K. B. 2004. Comparative sequence analysis of Bordetella bronchiseptica pertactin gene (prn) repeat region variants in swine vaccines and field isolates. Vaccine 23:48-57.
54. Register, K. B. 2001. Novel genetic and phenotypic heterogeneity in Bordetella bronchiseptica pertactin. Infect. Immun. 69:1917-1921.
55. Register, K. B., A. Boisvert, and M. R. Ackermann. 1997. Use of ribotyping to distinguish Bordetella bronchiseptica isolates. Int. J. Syst. Bacteriol. 47:678-683.
56. Register, K. B., T. F. Ducey, S. L. Brockmeier, and D. W. Dyer. 2001. Reduced virulence of a Bordetella bronchiseptica siderophore mutant in neonatal swine. Infect. Immun. 69:2137-2143.
57. Register, K. B., and T. Magyar. 1999. Optimized ribotyping protocol applied to Hungarian Bordetella bronchiseptica isolates: identification of two novel ribotypes. Vet. Microbiol. 69:277-285.
58. Relman, D., E. Tuomanen, S. Falkow, D. T. Golenbock, K. Saukkonen, and S. D. Wright. 1990. Recognition of a bacterial adhesion by an integrin: macrophage CR3 (αMβ2, CD11b/CD18) binds filamentous hemagglutinin of Bordetella pertussis. Cell 61:1375-1382.
59. Renauld-Mongenie, G., J. Cornette, N. Mielcarek, F. D. Menozzi, and C. Locht. 1996. Distinct roles of the N-terminal and C-terminal precursor domains in the biogenesis of the Bordetella pertussis filamentous hemagglutinin. J. Bacteriol. 178:1053-1060.
60. Roberts, M., J. P. Tite, N. F. Fairweather, G. Dougan, and I. G. Charles. 1992. Recombinant P.69/pertactin: immunogenicity and protection of mice against Bordetella pertussis infection. Vaccine 10:43-48.
61. Saif, L. J. 2004. Animal coronaviruses: what can they teach us about the severe acute respiratory syndrome? Rev. Sci. Technol. 23:643-660.
62. Saif, L. J., and R. D. Wesley. 1999. Transmissible gastroenteritis and porcine respiratory coronavirus, p. 295-326. In B. E. Straw, S. D'Allaire, W. L. Mengeling, and D. J. Taylor (ed.), Diseases of swine, 8th ed. Iowa State University Press, Ames.
63. Saukkonen, K., C. Cabellos, M. Burroughs, S. Prasad, and E. Tuomanen. 1991. Integrin-mediated localization of Bordetella pertussis within macrophages: role in pulmonary colonization. J. Exp. Med. 173:1143-1149.
64. Sekiya, K., M. Ohishi, T. Ogino, K. Tamano, C. Sasakawa, and A. Abe. 2001. Supermolecular structure of the enteropathogenic Escherichia coli type III secretion system and its direct interaction with the EspA-sheath-like structure. Proc. Natl. Acad. Sci. USA 98:11638-11643.
65. Simon, R., U. Priefer, and A. Puhler. 1983. A broad host range mobilization system for in vivo genetic engineering: transposon mutagenesis in gram-negative bacteria. Bio/Technology 1:784-791.
66. Tuomanen, E., H. Towbin, G. Rosenfelder, D. Braun, G. Larson, G. C. Hansson, and R. Hill. 1988. Receptor analogs and monoclonal antibodies that inhibit adherence of Bordetella pertussis to human ciliated respiratory epithelial cells. J. Exp. Med. 168:267-277. (Pubitemid 19014539)
67. Tuomanen, E., and A. Weiss. 1985. Characterization of two adhesins of Bordetella pertussis for human ciliated respiratory-epithelial cells. J. Infect. Dis. 152:118-125.
68. U.S. Department of Agriculture. 2008. Swine 2006. III. Reference of swine health and health management in the United States. USDA/APHIS/VS CEAH N478.0308. USDA, Fort Collins, CO.
69. Tuomanen, E., A. Weiss, R. Rich, F. Zak, and O. Zak. 1985. Filamentous hemagglutinin and pertussis toxin promote adherence of Bordetella pertussis to cilia. Dev. Biol. Stand. 61:197-204.
70. Urisu, A., J. L. Cowell, and C. R. Manclark. 1986. Filamentous hemagglutinin has a major role in mediating adherence of Bordetella pertussis to human WiDr cells. Infect. Immun. 52:695-701.
71. van den Berg, B. M., H. Beekhuizen, R. J. Willems, F. R. Mooi, and R. van Furth. 1999. Role of Bordetella pertussis virulence factors in adherence to epithelial cell lines derived from the human respiratory tract. Infect. Immun. 67:1056-1062.
72. Vecht, U., J. P. Arends, E. J. van der Molen, and L. A. van Leengoed. 1989. Differences in virulence between two strains of Streptococcus suis type II after experimentally induced infection of newborn germ-free pigs. Am. J. Vet. Res. 50:1037-1043.
73. Wu, H. Y., H. H. Nguyen, and M. W. Russell. 1997. Nasal lymphoid tissue (NALT) as a mucosal immune inductive site. Scand. J. Immunol. 46:506-513. (Pubitemid 27497638)
74. Zhang, X., K. Alekseev, K. Jung, A. Vlasova, N. Hadya, and L. J. Saif. 2008. Cytokine responses in porcine respiratory coronavirus-infected pigs treated with corticosteroids as a model for severe acute respiratory syndrome. J. Virol. 82:4420-4428.